INGN

Inogen Inc

Add to Watchlist

Advanced Chart

8.210

-0.03(-0.364%)1D

Line

Candle

YTD

High

8.260

Open

8.200

VWAP

8.16

Vol

206.85K

Mkt Cap

222.00M

Low

8.020

Amount

1.69M

EV/EBITDA(TTM)

Total Shares

26.89M

99.12M

EV/OCF(TTM)

P/S(TTM)

0.60

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

91.10M

+10.72%

-0.255

+2%

89.05M

+11.2%

-0.345

-15.85%

92.20M

+3.79%

-0.220

-12%

Estimates Revision

The market is revising Upward the revenue expectations for Inogen, Inc. (INGN) for FY2025, with the revenue forecasts being adjusted by 0.37% over the past three months. During the same period, the stock price has changed by 25.54%.

Revenue Estimates for FY2025

Revise Upward

+0.37%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-6.87%

In Past 3 Month

Stock Price

Go Up

+25.54%

In Past 3 Month

2 Analyst Rating

15.71% Upside

Wall Street analysts forecast INGN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INGN is 9.50 USD with a low forecast of 7.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

1 Sell

Hold

15.71% Upside

Current: 8.210

Low

7.00

Averages

9.50

High

12.00

15.71% Upside

Current: 8.210

Low

7.00

Averages

9.50

High

12.00

B. Riley

NULL -> Buy

initiated

$14

2025-06-17

Reason

B. Riley

Price Target

$14

2025-06-17

initiated

NULL -> Buy

Reason

B. Riley initiated coverage of Inogen with a Buy rating and $14 price target.

B. Riley

Anderson Schock

Buy

initiated

$14

2025-06-17

Reason

B. Riley

Anderson Schock

Price Target

$14

2025-06-17

initiated

Buy

Reason

Needham

Hold

Buy

upgrade

$12

2025-05-22

Reason

Needham

Price Target

$12

2025-05-22

upgrade

Hold

Buy

Reason

Needham

Mike Matson

Hold

Reiterates

n/a

2025-04-09

Reason

Needham

Mike Matson

Price Target

n/a

2025-04-09

Reiterates

Hold

Reason

Needham

Mike Matson

Hold

Reiterates

n/a

2025-02-27

Reason

Needham

Mike Matson

Price Target

n/a

2025-02-27

Reiterates

Hold

Reason

Needham

Mike Matson

Hold

Reiterates

n/a

2025-02-26

Reason

Needham

Mike Matson

Price Target

n/a

2025-02-26

Reiterates

Hold

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Inogen Inc (INGN.O) is -8.49, compared to its 5-year average forward P/E of -833.88. For a more detailed relative valuation and DCF analysis to assess Inogen Inc 's fair value, click here.

Forward PE
Forward EV/EBITDA
Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-833.88

Current PE

-8.49

Overvalued PE

2745.12

Undervalued PE

-4412.88

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

26.52

Current EV/EBITDA

341.20

Overvalued EV/EBITDA

175.35

Undervalued EV/EBITDA

-122.30

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Strongly Overvalued

5Y Average PS

1.48

Current PS

8.24

Overvalued PS

2.71

Undervalued PS

0.25